Add like
Add dislike
Add to saved papers

Predictive value of triglyceride/glucose index for cardiac outcomes in non-diabetic renal transplant recipients.

Acta Cardiologica 2023 September 29
OBJECTIVES: Insulin resistance (IR) is associated with an increased risk of adverse cardiovascular outcomes. The triglyceride-glucose index (TyG index) is a reliable marker of IR. No study has examined the impact of the TyG index on major adverse cardiac and cerebrovascular events (MACCEs) in RTRs. Therefore, this study aimed to investigate the predictive value of the TyG index for MACCEs in RTRs.

MATERIALS AND METHODS: Non-diabetic patients undergoing renal transplantation were retrospectively enrolled. The patients were divided into two groups according to MACCE development. The cut-off value of the TyG index for MACCE was conducted.

RESULTS: The mean age of 522 patients was 41 (31-51) years, and 349 (66.9%) were male. During the 5.4-year follow-up, 84 (16%) MACCE were recorded. TyG index was significantly higher in the group that developed MACCE ( p  < 0,001). Cox regression analysis revealed that TyG index [HR: 3.297 (1.228-8.855), p  = 0.018], left ventricle ejection fraction [HR: 0.934 (0.900-0.968), p  < 0.001], cadaveric transplantation [HR: 8.886 (4.764-16.576), p  < 0.001], graft survey [HR: 0.608 (0.542-0.682), p  < 0.001)], and smoking [HR: 1.965 (1.117-3.456), p  = 0.019] were independent predictors of MACCEs in nondiabetic RTRs.

CONCLUSION: TyG index is an independent predictor of MACCEs in non-diabetic RTRs. The widespread use of the TyG index may positively affect long-term treatment costs and survival.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app